BioCina
Charles Vincent is an experienced Information Technology professional with a robust background in IT management and validation. Currently serving as the Information Technology and CSV Manager at BioCina since October 2021, Charles develops IT strategies aligned with business objectives and oversees operational effectiveness. Previous roles include Computer Systems Validation Specialist at Pfizer, where responsibilities encompassed document creation and cross-functional training, and Field Technical Support L3 at DXC Technology, providing technical assistance to users. Charles's career also features significant positions in technical support and systems engineering at organizations such as Calibre One Pty Ltd, Infosys, and NIIT Limited, showcasing expertise in systems management, troubleshooting, and network performance optimization. Charles holds a Master's degree in Internet Technology from the University of Wollongong and a Bachelor's degree in Electrical, Electronics and Communications Engineering from Anna University Chennai.
This person is not in any teams
BioCina
BioCina is a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), offering highest-quality, cost-effective cell line, process, analytical and formulation development, and cGMP clinical & commercial manufacturing for the microbial, pDNA and mRNA modalities. BioCina’s first facility in Adelaide, South Australia is a testament to the quality of its work. It has a rich history of developing and manufacturing both clinical and commercial drug substance, backed by most critical SME’s having an average tenure of 15+ years at the site. BioCina boasts an elite quality record having successfully passed regulatory inspections by the US FDA, EMA and Health Canada. It is licensed by the Australian TGA for cGMP manufacturing of bulk drug substance or active intermediates. Through a partnership with NovaCina, BioCina offers clients a highest-quality fill-and-finish solution. BioCina is proud to have clients globally, including U.S., Europe, and the Asia Pacific. Because BioCina is not a drug developer, it only serves clients' products. As one of the fastest growing companies in the biopharmaceutical industry across Australia, BioCina was awarded the 2024 South Australia “Emerging Business of the Year” award. Learn more at https://biocina.com.